Paul Tomasic, Head of Houlihan Lokey’s European Healthcare team, explores how the primary driver of value in medtech is shifting from stand-alone product innovation to integrated infrastructure.
Writing in HealthInvestor UK, Mr. Tomasic argues that hospitals are increasingly prioritising efficiency, interoperability, and operational simplicity over incremental device improvements. As healthcare systems face mounting cost pressures and workforce shortages, buyers are turning towards integrated platforms that streamline procedures, connect devices, and embed data directly into clinical workflows.
You can read the article here.